As myeloproliferative neoplasms (MPN) are a particularly rare form of blood cancer without a clear cause, it may be difficult to understand how lifestyle factors can affect both MPN risk and symptom burden. What has research suggested about the ways certain lifestyle factors affect MPNs?
Multivariate analysis of patients with MPNs receiving antiplatelet or anticoagulation therapy revealed an increase in risk of bleeding events in these patients.
Two cases are presented to illustrate that DOACs are not efficacious in MPN-associated portal hypertension after TIPS procedure.
Investigators assessed studies for evidence to guide the management of MPN in patients with COVID-19.
As myeloproliferative neoplasms (MPNs) are a rare form of blood cancer, patients may not be aware of its effects. How do MPNs affect a patient’s quality of life, and what do your patients need to know?